pirch_latisse value detail aid

10
Indication LATISSE ® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. Important Safety Information Warnings and Precautions: In patients using LUMIGAN ® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE ® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN ® for IOP reduction should only use LATISSE ® after consulting with their physician and should be monitored for changes to their intraocular pressure. Please see additional Important Safety Information on the next page. After over 5 years on the market, LATISSE ® remains the first and only prescription treatment indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. With the 5-mL kit, introduced in 2012, practices could offer patients more solution in the bottle and more applicators, for more weeks of treatment in one kit. Find out how your practice can benefit with the LATISSE ® 5-mL kit. Stock up today! More solution = Real value 5-mL kit offers benefits to patients and practices For eyelash hypotrichosis

Upload: sarah-pirch

Post on 15-Feb-2017

243 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pirch_Latisse Value Detail Aid

IndicationLATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

Important Safety Information Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Please see additional Important Safety Information on the next page.

After over 5 years on the market, LATISSE® remains the first and only prescription treatment indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

With the 5-mL kit, introduced in 2012, practices could offer patients more solution in the bottle and more applicators, for more weeks of treatment in one kit.

Find out how your practice can benefit with the LATISSE® 5-mL kit.

Stock uptoday!

More solution = Real value5-mL kit offers benefits to patients and practices

For eyelash hypotrichosis

Page 2: Pirch_Latisse Value Detail Aid

Important Safety Information (continued)

Warnings and Precautions (continued): Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.

Please see additional Important Safety Information on the next page.

Approximately 544,000 patients have purchased LATISSE®1,*

Approximately 134,000 physicians have prescribed/dispensed LATISSE®2,†

Approximately 5.4 million kits sold3,‡

1 kit sold every 30 seconds, on average4,‡,§

LATISSE® by the numbersFor eyelash hypotrichosis

* As of October 2012. † As of December 2013. ‡ As of January 2014.§ Calculation based on total kits sold divided by total time (from January 2009 to January 2014).

Page 3: Pirch_Latisse Value Detail Aid

87% of LATISSE® users are very satisfied with their experience with LATISSE®5

91% are very likely to continue use of LATISSE®5

97% would recommend others talk with their doctor; 93% of them have recommended it to 7 people on average5

• A 10-week supply

• 67% more solution as compared to the 3-mL kit

• Suggested retail price per mL to patient of $35.80 for 5-mL kit vs $40 for 3-mL kit

• 11% cost savings vs the 3-mL kit

• Get to 16 weeks—full results—with 2 kits

5-mL kit• 5 weeks of treatment—see statistically significant increases in lash length and thickness, as seen in the pivotal clinical trial at week 4 vs vehicle6

• Entry-level size for first-time users

• Get to 16 weeks—full results—with 4 kits

3-mL kit

Value for your patientsFor eyelash hypotrichosis

Important Safety Information (continued)

Warnings and Precautions (continued): LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated.

Adverse Reactions: The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.

Please see additional Important Safety Information on the next page.

Page 4: Pirch_Latisse Value Detail Aid

Patients can learn more about Brilliant Distinctions® and sign up at BrilliantDistinctionsProgram.com.

E V E R Y

100 P O I N T S

$10 I N

S AV I N G S=

Patients earn points when they purchase Allergan aesthetics productsPatients redeem points for dollars off Allergan aesthetics products and treatments that can be spent in your office

Get patients signed up on the Brilliant Distinctions® provider portal

Brilliant Distinctions® points earned

150

100

5-mL kit

3-mL kit

Suggested retail price (per kit)

$179

$120

EARN MORE POINTS WITH THE 5-ML KIT!

Every LATISSE® purchase equals savingsFor eyelash hypotrichosis

LATISSE® and the Brilliant Distinctions® Program

Important Safety Information (continued)

Postmarketing Experience: The following reactions have been identified during postmarketing use of LATISSE® in clinical practice: burning sensation (eyelid), erythema periorbital, eye swelling, eyelid irritation, eyelid edema, eyelid pruritus, iris hyperpigmentation, lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), rash (including macular, erythematous, and pruritic limited to the eyelids and periorbital region), skin discoloration (periorbital), and vision blurred.

Please see additional Important Safety Information on the next page.

Page 5: Pirch_Latisse Value Detail Aid

79% of MDs are satisfied with the profit generated for their practice by LATISSE®7

87% of patients purchase their first kit in the office, and 1 in 4 purchase 2-plus kits initially5

82% of repeat LATISSE® purchasers buy their kits in the office5

• 10 weeks of treatment

• 67% more solution as compared to the 3-mL kit

• List price per mL to practice is $21.00 for 5-mL kit vs $24.00 for 3-mL kit

- 13% cost savings to practice per mL vs 3-mL kit

5-mL kit• 5 weeks of treatment

• 95% of LATISSE® users have purchased a 3-mL kit5

• 68% of new patients purchased the 3-mL kit—

suitable entry-level size5

3-mL kit

Value for your practiceFor eyelash hypotrichosis

Important Safety Information (continued)

Use in Specific Populations: Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.

Please see accompanying full Prescribing Information.

Page 6: Pirch_Latisse Value Detail Aid

Buy LATISSE®. Earn points. Save.

Earn points on LATISSE® purchases—advance through member levels and LATISSE® tiers

ALLERGAN PARTNER PRIVILEGES® points earned*

1 case of the 5-mL kits†

1 case of the 3-mL kits†

Wholesale list price (per kit)

EARN MORE POINTS WHEN YOU CHOOSE THE 5-ML KITS!

*Points are earned for direct purchases only. No points are earned for prescriptions written. †12 kits per case.

3

2

$105

$72

Get the most from your LATISSE® purchases with the ALLERGAN PARTNER PRIVILEGES® Program

For eyelash hypotrichosis

Track your progress onlineCheck your point totals, your ALLERGAN PARTNER PRIVLEGES® level, and your product tiers. Visit AllerganNetwork.com.

IndicationLATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.

Important Safety Information Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Please see additional Important Safety Information on the next page.

Page 7: Pirch_Latisse Value Detail Aid

• Awarded as you move up levels

• Member Rebates start at 4% at the Platinum Level and go up to 16%

Top 50 practices

Black Diamond (1500 points)

Diamond (1000 points)

Platinum Plus (650 points)

Platinum (400 points)

Gold (200 points)

up to 18%

up to 12%

up to 10%

up to 8%

up to 6%

up to 2%

2% rebate for 10 points each of 3 different product lines per quarter (Gold and above)

Silver20 points

Gold200 points

Platinum400 points — 4% rebate

Platinum Plus650 points — 6% rebate

Diamond1000 points — 8% rebate

Black Diamond

1500 points — 10% rebate

Top50

12% — 16% rebate• Awarded if you buy at least 10 points worth of

3 eligible products (30 points total) in a quarter

• The 2% rebate is applied to all your Allergan aesthetics purchases in a quarter

Get your 2% bonus rebate— buy LATISSE®

plus 2 other products in ALLERGAN PARTNER PRIVILEGES®

ALLERGAN PARTNER PRIVILEGES® Member Rebate up to 16% Portfolio Bonus Rebate 2%

REBATE POTENTIAL BY LEVEL

Boost your rebate with LATISSE®

Points earned on LATISSE® add up to rebates Your rebate percentage increases with each member level— plus get a 2% boost with the Portfolio Bonus Rebate

For eyelash hypotrichosis

Up to 18% in member rebates!

Important Safety Information (continued)

Warnings and Precautions (continued): Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.

Please see additional Important Safety Information on the next page.

Page 8: Pirch_Latisse Value Detail Aid

LATISSE® instant savings earned

Tier savings are on top of your member rebate

Tier 5 • 200 points

Tier 4 • 100 points

Tier 3 • 50 points

Tier 2 • 25 points

Tier 1 • 10 points

EARN MORE POINTS—ORDER TODAY

10%

8%

6%

4%

2%

Gain LATISSE® tiers—and instant savings Points earned on LATISSE® purchases place you in the LATISSE® tiers

For eyelash hypotrichosis

Up to 10% instant savings!

Important Safety Information (continued)

Warnings and Precautions (continued): LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated.

Adverse Reactions: The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.

Please see additional Important Safety Information on the next page.

Page 9: Pirch_Latisse Value Detail Aid

3 mL LATISSE® 3 mL

Top 10

Top 11-25

Top 26-50

Black Diamond

Diamond

Platinum Plus

Platinum

Gold

Silver

(Assumes Portfolio Bonus Rebate*)

TIER 5 TIER 4 TIER 3 TIER 2 TIER 1 TIER 0

$51.8 $53.3 $54.7 $56.2 $57.6 $59.0

$53.3 $54.7 $56.2 $57.6 $59.0 $60.5

$54.7 $56.2 $57.6 $59.0 $60.5 $61.9

$56.2 $57.6 $59.0 $60.5 $61.9 $63.4

$57.6 $59.0 $60.5 $61.9 $63.4 $64.8

$59.0 $60.5 $61.9 $63.4 $64.8 $66.2

$60.5 $61.9 $63.4 $64.8 $66.2 $67.7

$63.4 $64.8 $66.2 $67.7 $69.1 $70.6

$64.8 $66.2 $67.7 $69.1 $70.6 $72.0

What are you paying for LATISSE®? Lower your cost per kit with each level and tier you gain

For eyelash hypotrichosis

5 mL LATISSE® 5 mL

Top 10

Top 11-25

Top 26-50

Black Diamond

Diamond

Platinum Plus

Platinum

Gold

Silver

(Assumes Portfolio Bonus Rebate*)

TIER 5 TIER 4 TIER 3 TIER 2 TIER 1 TIER 0

$75.6 $77.7 $79.8 $81.9 $84.0 $86.1

$77.7 $79.8 $81.9 $84.0 $86.1 $88.2

$79.8 $81.9 $84.0 $86.1 $88.2 $90.3

$81.9 $84.0 $86.1 $88.2 $90.3 $92.4

$84.0 $86.1 $88.2 $90.3 $92.4 $94.5

$86.1 $88.2 $90.3 $92.4 $94.5 $96.6

$88.2 $90.3 $92.4 $94.5 $96.6 $98.7

$92.4 $94.5 $96.6 $98.7 $100.8 $102.9

$94.5 $96.6 $98.7 $100.8 $102.9 $105.0

*Important: The pricing here assumes that accounts have earned the Portfolio Bonus Rebate in addition to the ALLERGAN PARTNER PRIVILEGES® Member Rebate. • The Portfolio Bonus Rebate (2%) is awarded to Gold members and above who purchase 10 points each of 3 different product lines (30 points total) in a quarterly calendar period

Important Safety Information (continued)

Postmarketing Experience: The following reactions have been identified during postmarketing use of LATISSE® in clinical practice: burning sensation (eyelid), erythema periorbital, eye swelling, eyelid irritation, eyelid edema, eyelid pruritus, iris hyperpigmentation, lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), rash (including macular, erythematous, and pruritic limited to the eyelids and periorbital region), skin discoloration (periorbital), and vision blurred.

Please see additional Important Safety Information on the next page.

Page 10: Pirch_Latisse Value Detail Aid

©2014 Allergan, Inc., Irvine, CA 92612 ® marks owned by Allergan, Inc. www.latisse.com www.skinmedica.com APCXXXX14 141841

Contact your representative

Call Customer Service at 1-877-277-7764

Visit AllerganDirect.com

Stock up today!3 ways to order

For eyelash hypotrichosis

References: 1. Data on file, Allergan, Inc., October 2012. 2. Data on file, Allergan, Inc., December 2013. 3. Data on file, Allergan, Inc., January 2014. 4. Data on file, Allergan, Inc., January 2014. 5. Data on file, Allergan, Inc., June 2013; LATISSE® Consumer A&U 2Q-13. 6. Data on file, Allergan, Inc., 2008; Study No. 192024-032. 7. Data on file, Allergan, Inc., June 2013; LATISSE® Professional A&U 2Q-13.

Important Safety Information (continued)

Use in Specific Populations: Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.

Please see accompanying full Prescribing Information.